Correlation Between TG Therapeutics and Exelixis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Exelixis, you can compare the effects of market volatilities on TG Therapeutics and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Exelixis.

Diversification Opportunities for TG Therapeutics and Exelixis

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between TGTX and Exelixis is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Exelixis go up and down completely randomly.

Pair Corralation between TG Therapeutics and Exelixis

Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.94 times more return on investment than Exelixis. However, TG Therapeutics is 1.94 times more volatile than Exelixis. It trades about 0.35 of its potential returns per unit of risk. Exelixis is currently generating about 0.33 per unit of risk. If you would invest  2,313  in TG Therapeutics on August 24, 2024 and sell it today you would earn a total of  1,142  from holding TG Therapeutics or generate 49.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

TG Therapeutics  vs.  Exelixis

 Performance 
       Timeline  
TG Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Exelixis 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

TG Therapeutics and Exelixis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TG Therapeutics and Exelixis

The main advantage of trading using opposite TG Therapeutics and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.
The idea behind TG Therapeutics and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm